Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
J Environ Public Health ; 2022: 5991087, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-36213034

RESUMO

In order to improve the dynamic evaluation ability of medical image multimedia courseware-assisted teaching effect, the evaluation of medical image multimedia courseware-assisted teaching effect based on a deep learning algorithm is proposed. The statistical data analysis model of medical image multimedia courseware-assisted teaching effect is established to estimate its utilization rate and scale parameters. Based on the prediction of spatial attribute parameters, the classification big data mining model of medical image multimedia courseware-assisted teaching is constructed by using the deep learning algorithm, mining association rules and frequent item sets that can dynamically reflect the quality of medical image multimedia courseware-assisted teaching, and extracting the statistical feature of the dataset of constraint indicators of medical image multimedia courseware-assisted teaching effect to improve the teaching quality of medical imaging course. The simulation results show that this method has a better precision delivery effect, higher dynamic matching degree of teaching evaluation parameters, more than 90% reliability, and better clustering of statistical eigenvalues.


Assuntos
Instrução por Computador , Aprendizado Profundo , Simulação por Computador , Multimídia , Reprodutibilidade dos Testes
2.
Front Endocrinol (Lausanne) ; 13: 890900, 2022.
Artigo em Inglês | MEDLINE | ID: mdl-36704031

RESUMO

Introduction: This study aimed to investigate the relationship between Oxford Classification scores and longitudinal changes in proteinuria in patients with immunoglobulin A nephropathy (IgAN). Methods: The study was a single-center retrospective cohort study involving 358 patients with primary IgAN who were treated at the Shenzhen Second People's Hospital, China, between January 2011 and May 2021. Multivariate linear regression and generalized additive mixed models (GAMMs), adjusted for traditional risk confounders, were used to evaluate the correlation between scores for mesangial hypercellularity (M), endocapillary hypercellularity (E), segmental glomerulosclerosis (S), tubular atrophy/interstitial fibrosis (T), and crescents (C) (known as the Oxford Classification MEST-C score system), with proteinuria/creatinine ratio (PCR) at the time of renal biopsy and longitudinal changes in PCR, respectively. Results: The median PCR was 1061 mg/g, and it increased on average by 68.82 mg/g per year in these patients. Among patients with renal insufficiency, compared with patients without relative lesions, those with E present (E1) (1153.44; 95% confidence interval [CI], 188.99-2117.89 mg/g) and C > 0 (C1/2) (1063.58; 95% CI, 185.25-1941.90 mg/g) were associated with increased PCR levels at the time of renal biopsy. What's more, S present (S1) (194.96; 95% CI, 54.50-335.43 mg/g per year) was associated with the fastest PCR increase; C > 0 (C1/2) (147.59; 95% CI, 8.32-286.86 mg/g per year) and T >25% (T1/2) (77.04; 95% CI, 7.18-146.89 mg/g per year), were also correlated with a faster PCR increase. In patients with normal kidney function, associations between S1 (55.46; 95% CI, 8.93-101.99 mg/g per year) and E1 (94.02; 95% CI, 21.47-166.58 mg/g per year) and PCR change could be observed. Additionally, in patients with overweight/obesity, S1 (156.09; 95% CI, 52.41-259.77 mg/g per year), E1 (143.34; 95% CI, 35.30-251.38 mg/g per year), T1/2 (116.04; 95% CI, 22.58-209.51 mg/g per year), as well as C1/2 (134.03; 95% CI, 41.73-226.32 mg/g per year) were associated with noticeably quicker PCR increase. Conclusions: Overall, E1 and C1/2 were independently associated with raised proteinuria levels at the time of renal biopsy, and S1, E1, T1/2, C1/2 were independently associated with a longitudinal increase in proteinuria in the patients with IgAN, especially in those with renal insufficiency or overweight/obesity, suggesting that currently available treatments might not be satisfactory, and weight control might be beneficial. Individual therapy development might benefit from the use of the Oxford Classification system.


Assuntos
Glomerulonefrite por IGA , Insuficiência Renal , Humanos , Glomerulonefrite por IGA/complicações , Glomerulonefrite por IGA/patologia , Estudos Retrospectivos , Sobrepeso , Proteinúria/etiologia , Proteinúria/patologia , Obesidade
3.
Zhongguo Yi Xue Ke Xue Yuan Xue Bao ; 27(2): 216-22, 2005 Apr.
Artigo em Chinês | MEDLINE | ID: mdl-15960269

RESUMO

OBJECTIVE: To evaluate in vivo immunological protective efficacy and safety of expressed recombinant rotavirus epitopes in mice. METHODS: Using the Flock House virus capsid protein as a vector, three epitopes derived from rotavirus Vp4 amino acid 223-242 [rotavirus epitope A, (REA)], 243-262 [rotavirus epitope B, (REB)], and 234-251 [rotavirus epitope C, (REC)] were genetically engineered on the surface of the vector protein and expressed in pET-3 (E. coli BL21 [DE3]) system into multiple epitopes, REABC, which comprises REA, REB, and REC. Kunming strain mice were inoculated with the recombinant epitopes REABC, and then challenged perorally by cell culture-adapted rotavirus Wa (type G1P1A) and SA11 (type G3P2). Infection syndrome was observed, and virus antigen in stools of mice and serum neutralizing antibody activities were determined and analyzed. RESULTS: The recombinant epitopes REABC significantly induced rotavirus specific neutralyzing antibodies against WA and SA11, reduced virus reproduction, elicitted immune memory in inoculated mice, and protected inoculated mice from challenge by WA or SA11 (P<0.001). CONCLUSION: The recombinant epitopes have high immunological protective efficacy and mild side effects in mice. It may be used as an epitope-based vaccine candidate in human.


Assuntos
Proteínas do Capsídeo/imunologia , Capsídeo/metabolismo , Epitopos/biossíntese , Rotavirus/imunologia , Vacinas Virais , Animais , Antígenos Virais/imunologia , Capsídeo/imunologia , Epitopos/imunologia , Escherichia coli/genética , Feminino , Vetores Genéticos , Masculino , Camundongos , Proibitinas , Distribuição Aleatória , Proteínas Recombinantes/biossíntese , Proteínas Recombinantes/imunologia , Infecções por Rotavirus/imunologia , Infecções por Rotavirus/prevenção & controle , Vacinas Virais/imunologia
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA